- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Danske Invest-Bioteknologi Fund
+ Add to WatchlistDANIBIO:DC
162.5000 DKK 2.4000 1.50%As of 11:20:00 ET on 05/22/2013.
Snapshot for Danske Invest-Bioteknologi Fund (DANIBIO)
| Open: | 159.9000 | High - Low: | 162.5000 - 159.1000 | Primary Exchange: | Copenhagen |
|---|---|---|---|---|---|
| Volume: | 10,773 | 52-Week Range: | 120.0000 - 165.3000 | Beta vs BTK: | 0.8293 |
Fund Profile & Information for DANIBIO
Danske Invest Bioteknologi Fund is an open-end fund registered in Denmark. The Fund's objective is capital appreciation, and to outperform NASDAQ's biotech-index(NBI). The Fund invests worldwide in equity of biotechnology companies, and companies closely related to the biotechnology sector.
| Inception Date: | 2000-05-26 | Telephone: | 45-3333-7171 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.danskeinvest.dk | ||
Fundamentals for DANIBIO
| NAV | (on 2013-05-21) 158.0400 |
|---|---|
| Assets (M) | (on 2012-02-29) 233.4582 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | 1.30 |
| Average 52-Week % Premium | 0.8720 |
| Fund Leveraged | N |
Dividends for DANIBIO
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2013-04-17) 15.5000 |
| Dividend Yield (ttm) | 9.54% |
Performance for DANIBIO
| 1-Month | +8.62% | 1-Year | +36.08% |
|---|---|---|---|
| 3-Month | +25.10% | 3-Year | +22.56% |
| Year To Date | +36.70% | 5-Year | +28.86% |
| Expense Ratio | 1.50 |
Top Fund Holdings for DANIBIO
Filing Date: 03/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Biogen Idec Inc | 20,815 | 23,276,245 | 6.107% |
| Gilead Sciences Inc | 76,772 | 21,812,550 | 5.723% |
| Amgen Inc | 36,586 | 21,773,126 | 5.712% |
| Nektar Therapeutics | 336,658 | 21,499,148 | 5.641% |
| Incyte Corp Ltd | 155,391 | 21,118,687 | 5.541% |
| Affymetrix Inc | 764,508 | 20,949,018 | 5.496% |
| United Therapeutics Corp | 57,078 | 20,170,268 | 5.292% |
| Vertex Pharmaceuticals Inc | 60,293 | 19,241,205 | 5.048% |
| Celgene Corp | 28,170 | 18,956,030 | 4.973% |
| QIAGEN NV | 152,250 | 18,632,346 | 4.888% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page